{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:55:42Z","timestamp":1787169342670,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023320","name":"Catholic University of Korea College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28684","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T21:21:49Z","timestamp":1711142509000},"page":"e28684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel compound heterozygous mutations in SCN4A as a potential genetic cause contributing to myopathic manifestations: A case report and literature review"],"prefix":"10.1016","volume":"10","author":[{"given":"Ji Yoon","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-4234","authenticated-orcid":false,"given":"Joonhong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 11","key":"10.1016\/j.heliyon.2024.e28684_bib1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1113\/jphysiol.2010.186874","article-title":"Voltage-sensor mutations in channelopathies of skeletal muscle","volume":"588","author":"Cannon","year":"2010","journal-title":"J Physiol."},{"key":"10.1016\/j.heliyon.2024.e28684_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/164_2017_52","article-title":"Sodium channelopathies of skeletal muscle","volume":"246","author":"Cannon","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28684_bib3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1085\/jgp.87.6.907","article-title":"Na channel distribution in vertebrate skeletal muscle","volume":"87","author":"Caldwell","year":"1986","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.heliyon.2024.e28684_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2012.00112","article-title":"Pathophysiological role of omega pore current in channelopathies","volume":"3","author":"Jurkat-Rott","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"2 Pt 1","key":"10.1016\/j.heliyon.2024.e28684_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0006-3495(94)80807-0","article-title":"Slow Na+ channel inactivation must be disrupted to evoke prolonged depolarization-induced paralysis","volume":"66","author":"Ruff","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.heliyon.2024.e28684_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.1992.sp019407","article-title":"Na+ current densities and voltage dependence in human intercostal muscle fibres","volume":"458","author":"Ruff","year":"1992","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28684_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0404.1993.tb04072.x","article-title":"Paramyotonia congenita (Eulenburg): clinical, neurophysiological and muscle biopsy observations in a Swedish family","volume":"87","author":"Borg","year":"1993","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28684_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.24389","article-title":"Defective fast inactivation recovery of Nav1.4 in congenital myasthenic syndrome","volume":"77","author":"Arnold","year":"2015","journal-title":"Ann. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.heliyon.2024.e28684_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/brain\/awv352","article-title":"Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy","volume":"139","author":"Zaharieva","year":"2016","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e28684_bib10","doi-asserted-by":"crossref","first-page":"e1405","DOI":"10.1212\/WNL.0000000000007185","article-title":"Myasthenic congenital myopathy from recessive mutations at a single residue in Na(V)1.4","volume":"92","author":"Elia","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28684_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nmd.2017.02.001","article-title":"Congenital myopathy with \"corona\" fibres, selective muscle atrophy, and craniosynostosis associated with novel recessive mutations in SCN4A","volume":"27","author":"Gonorazky","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28684_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.0000000000003535","article-title":"Expanding the spectrum of congenital myopathy linked to recessive mutations in SCN4A","volume":"88","author":"Mercier","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2024.e28684_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.944784","article-title":"Case report: novel SCN4A variant associated with a severe congenital myasthenic syndrome\/myopathy phenotype","volume":"10","author":"Berghold","year":"2022","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28684_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp.70.5.618","article-title":"Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica","volume":"70","author":"Kim","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28684_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3346\/jkms.2002.17.6.856","article-title":"A Korean family with Arg1448Cys mutation of SCN4A channel causing paramyotonia congenita: electrophysiologic, histopathologic, and molecular genetic studies","volume":"17","author":"Kim","year":"2002","journal-title":"J. Kor. Med. Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28684_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.nmd.2004.07.005","article-title":"Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation","volume":"14","author":"Kim","year":"2004","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28684_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3346\/jkms.2007.22.6.946","article-title":"The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis","volume":"22","author":"Kim","year":"2007","journal-title":"J. Kor. Med. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28684_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3988\/jcn.2009.5.4.186","article-title":"Clinical diversity of SCN4A-mutation-associated skeletal muscle sodium channelopathy","volume":"5","author":"Lee","year":"2009","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28684_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.17340\/jkna.2015.3.9","article-title":"Electrodiagnostic findings and clinical characteristics of familial hyperkalemic periodic paralysis with a SCN4A Met1592Val mutation","volume":"28","author":"Lee","year":"2010","journal-title":"J. Korean Neurol. Assoc."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28684_bib20","first-page":"203","article-title":"A case of paramyotonia congenita without periodic paralysis: electrophysiological and molecular genetic studies","volume":"16","author":"Park","year":"2010","journal-title":"Neurol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28684_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3345\/kjp.2010.53.10.909","article-title":"An atypical phenotype of hypokalemic periodic paralysis caused by a mutation in the sodium channel gene SCN4A","volume":"53","author":"Park","year":"2010","journal-title":"Korean J. Pediatr."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28684_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3345\/kjp.2011.54.11.470","article-title":"Familial hyperkalemic periodic paralysis caused by a de novo mutation in the sodium channel gene SCN4A","volume":"54","author":"Han","year":"2011","journal-title":"Korean J. Pediatr."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28684_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3345\/kjp.2011.54.11.473","article-title":"Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations","volume":"54","author":"Kim","year":"2011","journal-title":"Korean J. Pediatr."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28684_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3988\/jcn.2015.11.4.331","article-title":"Whole-body muscle mri in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: evidence for chronic progressive myopathy with selective muscle involvement","volume":"11","author":"Lee","year":"2015","journal-title":"J. Clin. Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28684_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3988\/jcn.2016.12.4.509","article-title":"A large dominant myotonia congenita family with a V1293I mutation in SCN4A","volume":"12","author":"Chung","year":"2016","journal-title":"J. Clin. Neurol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28684_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nmd.2018.06.008","article-title":"Lower-extremity magnetic resonance imaging in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: 30-month follow-up of seven patients","volume":"28","author":"Jeong","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28684_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5049\/EBP.2021.19.1.10","article-title":"Confirming genetic abnormalities of hypokalemic periodic paralysis using next-generation sequencing: a case report and literature review","volume":"19","author":"Kim","year":"2021","journal-title":"Electrolyte Blood Press"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28684_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.heliyon.2024.e28684_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.761636","article-title":"A systematic review and meta-analysis of the prevalence of congenital myopathy","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28684_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0887-8994(01)00277-6","article-title":"Diagnostic profile of neonatal hypotonia: an 11-year study","volume":"25","author":"Richer","year":"2001","journal-title":"Pediatr. Neurol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28684_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/08830738050200100401","article-title":"The floppy infant: retrospective analysis of clinical experience (1990-2000) in a tertiary care facility","volume":"20","author":"Birdi","year":"2005","journal-title":"J. Child Neurol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28684_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00431-007-0539-3","article-title":"Diagnostic approach to neonatal hypotonia: retrospective study on 144 neonates","volume":"167","author":"Laugel","year":"2008","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28684_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28684_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/dmcn.14365","article-title":"Congenital myopathies: an update","volume":"62","author":"Claeys","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28684_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.mcn.2004.11.015","article-title":"Accumulation of Nav1 mRNAs at differentiating postsynaptic sites in rat soleus muscles","volume":"28","author":"Stocksley","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e28684_bib36","first-page":"314","article-title":"Physiological and pathophysiological insights of Nav1.4 and Nav1.5 comparison","volume":"6","author":"Loussouarn","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28684_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751095","article-title":"New challenges resulting from the loss of function of Na(v)1.4 in neuromuscular diseases","volume":"12","author":"Nicole","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"Pt 6","key":"10.1016\/j.heliyon.2024.e28684_bib38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/brain\/aww070","article-title":"Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis","volume":"139","author":"Wu","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28684_bib39","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1152\/physrev.00025.2020","article-title":"Sodium channelopathies of skeletal muscle and brain","volume":"101","author":"Mantegazza","year":"2021","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28684_bib40","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000267","article-title":"Homozygosity for SCN4A Arg1142Gln causes congenital myopathy with variable disease expression","volume":"4","author":"Sloth","year":"2018","journal-title":"Neurol. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28684_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.0000000000002264","article-title":"A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis","volume":"86","author":"Habbout","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28684_bib42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.braindev.2015.02.004","article-title":"New phenotype and neonatal onset of sodium channel myotonia in a child with a novel mutation of SCN4A gene","volume":"37","author":"Fusco","year":"2015","journal-title":"Brain Dev."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28684_bib43","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1007\/s10072-021-05537-z","article-title":"Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome","volume":"42","author":"Rigamonti","year":"2021","journal-title":"Neurol. Sci."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e28684_bib44","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1111\/jcmm.17417","article-title":"Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre","volume":"26","author":"Huang","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28684_bib45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneur.1990.00530090091018","article-title":"Progressive myopathy in hyperkalemic periodic paralysis","volume":"47","author":"Bradley","year":"1990","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28684_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28684_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nmd.2021.07.400","article-title":"Congenital myasthenic syndromes: where do we go from here?","volume":"31","author":"Ramdas","year":"2021","journal-title":"Neuromuscul. Disord."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024047157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024047157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:21:16Z","timestamp":1784208076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024047157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024047157"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28684","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel compound heterozygous mutations in SCN4A as a potential genetic cause contributing to myopathic manifestations: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28684"}}